Lulibet XL Cream contains Luliconazole 1% w/w, an imidazole antifungal agent indicated for the topical treatment of superficial dermatophytic infections, including tinea corporis, tinea cruris, and tinea pedis. Luliconazole exhibits potent fungicidal activity by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The cream formulation facilitates effective skin penetration, ensuring targeted delivery to the site of infection. Lulibet XL Cream is applied once daily to the affected area and surrounding skin, typically for a duration of 2 to 4 weeks depending on the severity and type of infection. It is well tolerated with minimal adverse effects, which may include mild local irritation, burning sensation, or erythema at the application site. Contraindications include hypersensitivity to luliconazole or any excipients in the formulation. Caution is advised in patients with extensive skin lesions or those with known sensitivity to azole antifungals. Lulibet XL Cream offers a convenient and effective therapeutic option for managing superficial fungal infections, promoting rapid symptom relief and resolution of infection when used as directed under medical supervision.